Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer
Authors
Keywords
-
Journal
MOLECULAR MEDICINE
Volume 27, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-03
DOI
10.1186/s10020-021-00331-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genotype-specific differences in circulating tumor DNA levels in advanced NSCLC
- (2021) Vincent K. Lam et al. Journal of Thoracic Oncology
- Integrating genomic features for non-invasive early lung cancer detection
- (2020) Jacob J. Chabon et al. NATURE
- Clinicopathological parameters for circulating tumor DNA shedding in surgically resected non-small cell lung cancer with EGFR or KRAS mutation
- (2020) Min-Sun Cho et al. PLoS One
- Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study
- (2020) Yuqiong Lei et al. LUNG CANCER
- High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survival
- (2020) Jouni Kujala et al. Cancer Medicine
- Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization
- (2019) Luna Kadouri et al. LUNG CANCER
- Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Cell-Free DNA in Stage I–IV Non–Small Cell Lung Cancer
- (2019) John Jiang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- False positive plasma genotyping due to clonal hematopoiesis
- (2018) Yuebi Hu et al. CLINICAL CANCER RESEARCH
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- Biological background of the genomic variations of cf-DNA in healthy individuals
- (2018) J Liu et al. ANNALS OF ONCOLOGY
- Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies
- (2018) Yi-Long Wu et al. LUNG CANCER
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
- (2018) Charu Aggarwal et al. JAMA Oncology
- Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens
- (2017) Judith N. Müller et al. Journal of Thoracic Oncology
- Cell‐Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta‐Analysis
- (2017) Karen‐Lise G. Spindler et al. ONCOLOGIST
- Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis
- (2017) Ziqiang Lin et al. Oncotarget
- Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients
- (2017) Florence Koeppel et al. PLoS One
- GenVisR: Genomic Visualizations in R
- (2016) Zachary L. Skidmore et al. BIOINFORMATICS
- Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
- (2016) J. C. Thompson et al. CLINICAL CANCER RESEARCH
- Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)
- (2016) C. Karlovich et al. CLINICAL CANCER RESEARCH
- Scientific Advances in Lung Cancer 2015
- (2016) Anne S. Tsao et al. Journal of Thoracic Oncology
- The diagnostic value of circulating cell free DNA quantification in non-small cell lung cancer: A systematic review with meta-analysis
- (2016) Tao Jiang et al. LUNG CANCER
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors
- (2016) Xiaohua Shi et al. Oncotarget
- Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis
- (2016) Yunhe Gao et al. Oncotarget
- CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
- (2016) Eric Talevich et al. PLoS Computational Biology
- Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
- (2016) Lynnette Fernandez-Cuesta et al. EBioMedicine
- Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis
- (2016) Quan Zhou et al. PLoS One
- EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs
- (2015) Y. Kobayashi et al. CLINICAL CANCER RESEARCH
- Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
- (2015) A. Patnaik et al. CLINICAL CANCER RESEARCH
- Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials
- (2015) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients
- (2015) Antonio Marchetti et al. Journal of Thoracic Oncology
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
- (2015) Matthew J. Niederst et al. Nature Communications
- Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
- (2015) G. M. Frampton et al. Cancer Discovery
- Liquid biopsies in lung cancer: The new ambrosia of researchers
- (2014) Christian Rolfo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Clinical next-generation sequencing in patients with non-small cell lung cancer
- (2014) Ian S. Hagemann et al. CANCER
- Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
- (2014) Jean-Yves Douillard et al. Journal of Thoracic Oncology
- Smoking, p53 Mutation, and Lung Cancer
- (2014) Don L. Gibbons et al. MOLECULAR CANCER RESEARCH
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer
- (2014) Kun Nie et al. TUMOR BIOLOGY
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
- (2012) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- Combined SCLC Clinical and Pathologic Characteristics
- (2012) Shahab Babakoohi et al. Clinical Lung Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now